METTL2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.868400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.349900E-02
Normal-vs-Stage2
3.740800E-01
Normal-vs-Stage3
4.209200E-01
Normal-vs-Stage4
5.405600E-01
Stage1-vs-Stage2
4.488800E-01
Stage1-vs-Stage3
8.480900E-03
Stage1-vs-Stage4
4.256200E-01
Stage2-vs-Stage3
7.202300E-02
Stage2-vs-Stage4
8.645600E-01
Stage3-vs-Stage4
2.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.985000E-01
Normal-vs-AfricanAmerican
3.368600E-01
Normal-vs-Asian
5.413400E-01
Caucasian-vs-AfricanAmerican
6.183400E-01
Caucasian-vs-Asian
7.685400E-01
AfricanAmerican-vs-Asian
5.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.193800E-01
Normal-vs-Female
3.561800E-01
Male-vs-Female
7.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.454000E-01
Normal-vs-Age(41-60Yrs)
1.758410E-01
Normal-vs-Age(61-80Yrs)
5.190000E-01
Normal-vs-Age(81-100Yrs)
4.497600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.134200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.444600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.387000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.958000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.054200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.867000E-01
Normal-vs-Daily Drinker
6.701200E-01
Normal-vs-Weekly Drinker
4.170600E-01
Normal-vs-Occasional Drinker
2.394200E-01
Normal-vs-Social Drinker
1.470850E-01
Non Drinker-vs-Daily Drinker
7.581200E-01
Non Drinker-vs-Weekly Drinker
1.606600E-01
Non Drinker-vs-Occasional Drinker
1.297960E-01
Non Drinker-vs-Social Drinker
3.860900E-03
Daily Drinker-vs-Weekly Drinker
2.659400E-01
Daily Drinker-vs-Occasional Drinker
2.334000E-01
Daily Drinker-vs-Social Drinker
1.175770E-02
Weekly Drinker-vs-Occasional Drinker
8.209200E-01
Weekly Drinker-vs-Social Drinker
2.618800E-01
Occasional Drinker-vs-Social Drinker
1.084570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.025800E-01
Normal-vs-Grade 2
8.260200E-01
Normal-vs-Grade 3
7.466000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.033000E-01
Grade 1-vs-Grade 3
4.177700E-02
Grade 1-vs-Grade 4
9.025800E-01
Grade 2-vs-Grade 3
9.985600E-02
Grade 2-vs-Grade 4
8.260200E-01
Grade 3-vs-Grade 4
7.466000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.729400E-01
Normal-vs-NonDiabetic
3.629000E-01
Diabetic-vs-NonDiabetic
2.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.434800E-01
Normal-vs-NoPancreatitis
4.195000E-01
Pancreatitis-vs-NoPancreatitis
7.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.833000E-01
Normal-vs-N1
3.952200E-01
N0-vs-N1
7.844400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.548600E-01
Normal-vs-TP53-NonMutant
5.423200E-01
TP53-Mutant-vs-TP53-NonMutant
7.590000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
